CRO and ICP have soared the most from the top 100 alts, as both are up by double digits.
That all happened in the span of 36 hours. The past day brought another leg up that drove BTC to just under $30,000. However, it failed there and has since lost several hundred dollars.This is all you need not to miss any price action in the raging crypto markets. Start receiving this recap, for free, every day:Nevertheless, BTC still stands above $29,000, and its market cap remains north of $560 billion. Its dominance over the alts is up to 47%.
Ripple, Dogecoin, MATIC, Solana, Litecoin, and Tron are also slightly in the red from the larger-cap alts. In contrast, Binance Coin, Cardano, Polkadot, and Shiba Inu have retraced daily. The biggest gainers in the past day are ICP and CRO. The project behind the latter made two massive partnerships this week, with Amazon and Samsung, that propelled yet another price surge. Overall, both assets have pumped by 11%.
These gains have helped the total crypto market cap add $15 billion daily, and the metric sits just north of $1.2 trillion.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
17 People Who Were Wrongity Wrong Wrong Wrong This MonthI love watching someone being 100% wrong on the internet with 100% confidence.
Read more »
CRO Spikes 13% Following a Partnership Between Amazon and CronosCRO suprassed $0.07 hours after AWS teamed up with Cronos Labs.
Read more »
One Dead as Hellish Fire Annihilates 100+ Homes in RussiaAlmost 400 emergency services personnel were sent to tackle the blaze.
Read more »
Bitcoin Reclaims $28K While Radix (XRD) Explodes 22% Daily (Market Watch)CRO is today's top performer within the top 50 alts with a massive 13% surge.
Read more »
Johns Hopkins’ Revolutionary New Gel Cured 100% of Mice With Aggressive Brain CancerA novel hydrogel developed by Johns Hopkins University researchers cured 100% of mice with aggressive brain cancer by combining anticancer drugs and antibodies to target lingering cancer cells and trigger an immune response against glioblastoma. Medication delivered by a novel gel cured 100% of m
Read more »